Navigation Links
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
Date:11/16/2009

and Subsidiary Consolidated Balance Sheets (unaudited) September 30, June 30, 2009 2009 ------------- ------------ ASSETS Current assets: Cash and cash equivalents $4,188,173 $4,378,662 Available-for-sale investments 3,466,673 3,439,650 Accounts receivable 3,233,278 508,528 Prepaid expenses and other current assets 364,239 492,824 ------- ------- Total current assets 11,252,363 8,819,664 Property and equipment, net 3,338,705 3,650,783 Restricted cash 475,000 475,000 Other assets 250,022 254,364 ------- ------- Total assets $15,316,090 $13,199,811 =========== =========== LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Capital lease obligations $45,154 $87,675 Accounts payable 410,984 206,363 Accrued expenses 1,048,974 1,420,741 Deferred revenue 6,311,416 6,955,553 --------- --------- Total current liabilities 7,816,528 8,670,332 Capital lease obligations 29,224 33,954 Deferred rent 1,056,673 1,182,026
'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
2. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
3. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
4. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
5. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
6. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
7. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
8. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
9. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
10. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
11. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA theory ... of these latent viruses is the Epstein Barr Virus (EBV), ... arthritis (RA) is a chronic inflammatory disease that destroys the ... that RA patients have high concentrations of EBV DNA in ...
(Date:1/15/2014)... January 15, 2014 Freeslate, Inc ... today announced that Lupin Limited, one of India’s top ... CM Protégé PharmD System for high throughput solid ... is focused on a wide range of quality, affordable ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, April ... Location: Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... nonprofit organization solely dedicated to finding a cure for hepatitis ... worldwide, will host its annual Crystal Ball on Friday, April ...
(Date:1/14/2014)... 14, 2014  3D Communications, a leading provider of strategic communications services ... media events in the United States and ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as Associate ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... ViroPharma Incorporated (Nasdaq: VPHM ) today announced that ... investment conferences. , Vincent Milano, president and chief ... 20th Annual Healthcare Conference at 4:30 P.M. EST on ... held at the Waldorf=Astoria in New York City. , ...
... 50/50 joint venture agreement signed with Hunan, Biopharmaceutical ... manufacturing facility, - Biologics: 23% growth in sales and to ... of KINLYTIC(TM) thrombolytic, agent for pulmonary embolism, ... under, agreement, - Dr. Mark ...
... DNDN ) today announced that management will present at the following upcoming ... New York City, Tuesday, November 10, 2009, ... Phoenix, Arizona, Friday, November 13, 2009, ... Conference, New York City, Tuesday, November 17, ...
Cached Biology Technology:ViroPharma to Present at Three November Healthcare Conferences 2Microbix Biosystems Provides a Corporate Update 2Microbix Biosystems Provides a Corporate Update 3Microbix Biosystems Provides a Corporate Update 4Microbix Biosystems Provides a Corporate Update 5Microbix Biosystems Provides a Corporate Update 6Microbix Biosystems Provides a Corporate Update 7
(Date:4/20/2014)... analysis growing in importance for both basic researchers ... and the University of Maryland have developed a ... of gene activity from RNA sequencing (RNA-seq) data., ... famously speedy fish, estimates of gene expression that ... a few minutes, with accuracy that equals or ...
(Date:4/20/2014)... Although doctors have long known that people with Down ... leukemia (ALL) during childhood, they haven,t been able to ... Institute investigators has uncovered a connection between the two ... the journal Nature Genetics , the researchers track ... abnormality in Down syndrome to the cellular havoc that ...
(Date:4/18/2014)... techniques like X-ray crystallography and nuclear magnetic resonance imaging ... of molecules, but such efforts have long been hampered ... a specific molecule and often in ordered and crystalized ... impossible to peer into the structure of most molecules. ... be a thing of the past. , A ...
Breaking Biology News(10 mins):Computational method dramatically speeds up estimates of gene expression 2Dana-Farber researchers uncover link between Down syndrome and leukemia 2Dana-Farber researchers uncover link between Down syndrome and leukemia 3MRI, on a molecular scale 2MRI, on a molecular scale 3
... voices, but now helium is also helping people with ... the University of Alberta in Edmonton, Canada have discovered ... allowed patients with chronic obstructive pulmonary disease (COPD) to ... per cent. COPD is a disease of the lungs ...
... For the first time in humans, scientists have found ... injuries caused by repetitive motion. , Their findings ... debilitating conditions such as carpal tunnel syndrome and tendonitis. ... researchers Ann Barr and Mary Barbe and their doctoral ...
... Two researchers from the University Hospital and the Center ... Navarra have published an article in Nature Cancer ... the area of cancer studies. The article, written by ... from the United States and Great Britain, addresses the ...
Cached Biology News:Helium helps patients breathe easier 2Red flag for repetitive stress injuries identified for first time in humans 2Researchers from the University of Navarra analyze new kinds of cancer-fighting antibodies 2